Planned phase I trial of PAN 622 in hepatocellular carcinoma

Trial Profile

Planned phase I trial of PAN 622 in hepatocellular carcinoma

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2007

At a glance

  • Drugs PAN 622 (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Dec 2007 This trial is expected to begin in early 2009.
    • 07 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top